Cargando…
High Dose Intravenous Vitamin C as Adjunctive Therapy for COVID-19 Patients with Cancer: Two Cases
Background: Related to the SARS-CoV-2 pandemic leading to COVID-19 illness, patients with cancer comorbidity are known to have a higher risk of developing severe viral-related events, including death. To date, there are few treatments with proven efficacy for COVID-19. Vitamin C administered intrave...
Autores principales: | Guo, Guangling, Chen, Qi, Luo, Guoshi, Meng, Zhongji, Lei, Pan, Chen, Ping, Drisko, Jeanne A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953706/ https://www.ncbi.nlm.nih.gov/pubmed/35330086 http://dx.doi.org/10.3390/life12030335 |
Ejemplares similares
-
Pilot trial of high-dose vitamin C in critically ill COVID-19 patients
por: Zhang, Jing, et al.
Publicado: (2021) -
Treatment of pancreatic cancer with intravenous vitamin C: a case report
por: Drisko, Jeanne A., et al.
Publicado: (2018) -
Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse Effects
por: Padayatty, Sebastian J., et al.
Publicado: (2010) -
Pharmacokinetic Evaluation of Intravenous Vitamin C: A Classic Pharmacokinetic Study
por: Chen, Ping, et al.
Publicado: (2022) -
Intravenous Vitamin C Administered as Adjunctive Therapy for Recurrent Acute Respiratory Distress Syndrome
por: Bharara, Amit, et al.
Publicado: (2016)